Étude des projections axonales sérotoninergiques dans un modèle murin de la maladie de Parkinson et des dyskinésies induites par la lévodopa

Authors: Couture, Charles-Étienne
Advisor: Parent, Martin
Abstract: Objectives: The release of dopamine by serotonin (5-HT) afferent projections of the striatum is known to be a major pre-synaptic determinant of L-Dopa-induced dyskinesia, a debilitating side effect of the pharmacological treatment of the Parkinson’s disease. The fact that 5-HT axons are able to release dopamine in a nonphysiological manner following the administration of L-Dopa might lead to the expression of dyskinesias. Some striatal 5-HT axons are known to contain VGluT3 and we hypothesize that this vesicular glutamate transporter has a synergic effect on dopamine packaging into synaptic vesicles and its release. The main goal of this research project is to measure VGluT3 in 5-HT striatal afferent projections and to evaluate its role in the expression of dyskinesias. Methods: Eighteen C57Bl6 mice were divided in 3 experimental groups. Twelve mice received intracerebral injection of 6-hydroxydopamine (6-OHDA) in the medial forebrain bundle to lesion the striatal dopaminergic afferent projections. Systematic daily injections of L-Dopa (during 12 days) were administrated in 6 of these 6-OHDA-lesioned mice. The other 6 mice received injections of the vehicle only and served as controls. The abnormal involuntary movements (the equivalent of dyskinesias in primates) were scored using a well-known and widely used motor scale. Double immunofluorescence for the 5-HT membrane transporter (SERT) and VGluT3 was performed to evaluate the density of immunolabeled axon varicosities and assess statistical differences between the 3 experimental groups. Results: Among the 3 groups, only a small percentage of 5-HT axonal varicosities express VGluT3 and these doubly labeled varicosities often occur along the same axonal branch. There is no significant difference between the 3 experimental groups regarding the density of SERT or SERT/VGluT3 axon varicosities in the dorsal striatum. Conclusion: Our data indicate that the density of SERT or SERT/VGluT3 immunolabeled axon varicosities in the dorsal striatum is not correlated with the severity or the expression of abnormal involuntary movement following L-Dopa administration
Document Type: Mémoire de maîtrise
Issue Date: 2016
Open Access Date: 24 April 2018
Permalink: http://hdl.handle.net/20.500.11794/26917
Grantor: Université Laval
Collection:Thèses et mémoires

Files in this item:
Description SizeFormat 
32586.pdfTexte12.79 MBAdobe PDFThumbnail
All documents in CorpusUL are protected by Copyright Act of Canada.